Here's What Key Metrics Tell Us About CareDx (CDNA) Q2 Earnings

Group 1 - CareDx reported revenue of $86.68 million for the quarter ended June 2025, a year-over-year decline of 6.1% and an EPS of $0.10 compared to $0.25 a year ago [1] - The revenue surprise was -4.45% compared to the Zacks Consensus Estimate of $90.72 million, and the EPS surprise was -16.67% against the consensus estimate of $0.12 [1] - CareDx's shares have returned -33.3% over the past month, while the Zacks S&P 500 composite increased by +0.5% [3] Group 2 - Revenue from Patient and digital solutions was $12.81 million, exceeding the average estimate of $11.91 million, representing a year-over-year change of +19.2% [4] - Revenue from Testing services was $62.03 million, below the average estimate of $67.39 million, indicating a year-over-year decline of -12.5% [4] - Revenue from Product sales was $11.83 million, slightly above the average estimate of $11.69 million, reflecting a year-over-year increase of +11.5% [4]